Essex Savings Bank Gilead Sciences, Inc. Transaction History

Essex Savings Bank

$398 Million
Q3 2024

A detailed history of Essex Savings Bank transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Essex Savings Bank holds 4,684 shares of GILD stock, worth $430,365. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,684

Previous 4,607 1.67%

Holding current value

$430,365

Previous $316,000 24.05%

% of portfolio

0.1%

Previous 0.09%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$66.59 - $83.99 $5,127 - $6,467	77 Added 1.67%	4,684 $392,000
Q2 2024 Jul 23, 2024	BUY	$63.15 - $72.88 $3,789 - $4,372	60 Added 1.32%	4,607 $316,000
Q4 2023 Jan 22, 2024	BUY	$73.27 - $83.09 $17,584 - $19,941	240 Added 5.57%	4,547 $368,000
Q3 2023 Oct 12, 2023	BUY	$73.94 - $80.67 $48,652 - $53,080	658 Added 18.03%	4,307 $322,000
Q2 2023 Jul 19, 2023	SELL	$76.01 - $86.7 $55,867 - $63,724	-735 Reduced 16.77%	3,649 $281,000
Q1 2023 Apr 24, 2023	BUY	$77.31 - $88.08 $5,566 - $6,341	72 Added 1.67%	4,384 $363,000
Q4 2022 Jan 18, 2023	SELL	$62.32 - $89.47 $39,573 - $56,813	-635 Reduced 12.84%	4,312 $0
Q3 2022 Oct 19, 2022	BUY	$59.54 - $68.01 $1,488 - $1,700	25 Added 0.51%	4,947 $305,000
Q2 2022 Jul 19, 2022	BUY	$57.72 - $65.01 $12,467 - $14,042	216 Added 4.59%	4,922 $304,000
Q1 2022 May 03, 2022	SELL	$57.92 - $72.58 $38,343 - $48,047	-662 Reduced 12.33%	4,706 $280,000
Q4 2021 Feb 23, 2022	BUY	$64.88 - $73.64 $69,291 - $78,647	1,068 Added 24.84%	5,368 $390,000
Q3 2021 Oct 20, 2021	BUY	$67.69 - $73.03 $19,765 - $21,324	292 Added 7.29%	4,300 $313,000
Q2 2021 Jul 29, 2021	SELL	$63.47 - $69.35 $33,892 - $37,032	-534 Reduced 11.76%	4,008 $265,000
Q1 2021 Apr 22, 2021	SELL	$60.0 - $68.46 $46,380 - $52,919	-773 Reduced 14.54%	4,542 $279,000
Q4 2020 Feb 03, 2021	SELL	$56.65 - $64.55 $38,182 - $43,506	-674 Reduced 11.25%	5,315 $310,000
Q3 2020 Oct 26, 2020	BUY	$62.1 - $78.08 $100,105 - $125,864	1,612 Added 36.83%	5,989 $378,000
Q2 2020 Jul 30, 2020	BUY	$72.34 - $84.0 $316,632 - $367,668	4,377 New	4,377 $337,000
Q3 2019 Oct 30, 2019	SELL	$62.51 - $69.0 $191,218 - $211,071	-3,059 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$61.87 - $69.38 $115,016 - $128,977	1,859 Added 154.92%	3,059 $207,000
Q1 2019 May 06, 2019	BUY	$62.53 - $70.05 $8,691 - $9,736	139 Added 13.1%	1,200 $78,000
Q4 2018 Feb 01, 2019	BUY	$60.54 - $79.0 $64,232 - $83,819	1,061 New	1,061 $66,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Essex Savings Bank with notifications on news.

Account

Essex Savings Bank Gilead Sciences, Inc. Transaction History